Untangling GLP-1 Risks: Are Side Effects Overblown?

(MedPage Today) — In part two of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, Karl Nadolsky, DO, and Fatima Cody Stanford, MD, MPH, MPA, MBA, dive into the complexities of GLP-1 receptor agonists…

Powered by WPeMatico